The Food and Drug Administration (FDA) on March 17 published a final guidance on reprocessing reusable medical devices. This guidance, which provides manufacturers with recommendations to validate their reprocessing instructions, comes on the heels of a host of “superbug” bacteria outbreaks related to reprocessing of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes.
Ensuring safe, quality care requires precise alignment among inventory levels,…
CEO Karen Franco, MBA, spent years struggling to fill surgical…
Immersed in texts, apps, QR codes, and streaming videos, we…